Intermediate declaration by the Board of Directors

Regulatory News:

Highlights Q4 2021:

› Revenue was USD 172.3 million, within the guidance of USD 170-180 million, up 27% year-on-year (YoY) and up 2% quarter-on-quarter (QoQ)

› Record quarterly bookings at USD 249.5 million, up 31% YoY and 25% QoQ

› EBITDA margin of 19.7%, within the 19-23% guidance

› EBITDA was USD 33.9 million, up 51% YoY and down 16% QoQ

› EBIT was USD 14.2 million, up USD 10.6 million YoY and down USD 7.2 million QoQ

Highlights 2021:

› Revenue was USD 657.8 million, within the guided USD 655-665 million, up 38% year-on-year (YoY)

› Consistently strong demand across all end markets with total bookings amounting to USD 868.4 million

› EBITDA margin of 23.3%, within the 23-24% guidance

› EBITDA was USD 153.3 million, up USD 92.8 million, up 154% YoY

› EBIT was USD 77.2 million, up 91.8 million YoY

Outlook:

› Q1 2022 revenue is expected in the range of USD 175-185 million with an EBITDA margin in the range of 19-23%. The guidance is based on an average exchange rate of 1.14 USD/Euro.

› Full-year revenues expected in the range of USD 750-815 million with an EBITDA margin in the range of 21-25%.

Revenue breakdown per quarter:

in millions of USD

Q1 2020

Q2 2020

Q3 2020

Q4 2020

Q1 2021

Q2 2021

Q3 2021

Q4 2021

Q4 y-o-y growth

Automotive

68.3

61.6

40.8

65.4

83.5

82.8

81.5

83.8

28%

Industrial

22.1

23.9

23.9

27.3

32.4

35.2

38.3

39.7

46%

Medical

6.5

7.3

7.7

12.0

8.7

10.4

14.3

14.5

21%

Subtotal core business

96.9

92.7

72.3

104.7

124.6

128.4

134.1

138.0

32%

76.4%

78.1%

75.2%

77.1%

80.1%

79.8%

79.3%

80.1%

 

CCC1

29.7

25.9

23.7

30.9

30.6

32.4

34.7

34.0

10%

Others

0.3

0.2

0.1

0.3

0.3

0.1

0.3

0.3

 

Total revenues

126.9

118.8

96.1

135.9

155.4

161.0

169.1

172.3

27%

  1. Consumer, Communications & Computer

in millions of USD

Q1 2020

Q2 2020

Q3 2020

Q4 2020

Q1 2021

Q2 2021

Q3 2021

Q4 2021

Q4 y-o-y growth

CMOS

112.8

103.4

81.1

115.0

134.9

137.5

141.8

144.2

25%

MEMS

9.6

10.4

9.8

14.6

14.4

16.2

17.4

17.5

20%

Silicon carbide

4.5

5.0

5.2

6.3

6.1

7.2

9.9

10.6

70%

Total revenues

126.9

118.8

96.1

135.9

155.4

161.0

169.1

172.3

27%

Business development

Revenues in the fourth quarter came in at USD 172.3 million, within the guided USD 170-180 million, up 27% year-on-year and 2% quarter-on-quarter. Full year revenues reached USD 657.8 million, up 38% against the previous year. X-FAB has achieved new annual and quarterly sales records, following five quarters of consecutive growth.

Quarterly revenues in X-FAB’s core markets – namely automotive, industrial, and medical – amounted to USD 138.0 million, up 32% year-on-year and 3% quarter-on-quarter. For the full year 2021, revenue in the core markets totaled USD 525.1 million, up 43% against 2020. Ongoing electrification in the automotive and industrial markets was a major growth driver in 2021, pushing demand for X-FAB’s silicon carbide technology as well as supporting applications required in electric vehicles. X-FAB’s medical business benefited from the pandemic-related need for testing as well as point-of-care devices with lab-on-a-chip applications recording the strongest growth.

X-FAB’s CCC revenue (Consumer, Communications & Computer) was up 10% year-on-year in the fourth quarter and up 19% year-on-year for the full year. While the CCC legacy business manufactured at X-FAB France gradually decreased in line with expectations over the course of 2021, interest in X-FAB’s RF SOI technology picked up significantly, driven by the increased deployment of 5G.

The year 2021 was marked by tremendous demand with fourth quarter bookings reaching an all-time high of USD 249.5 million, up 31% year-on-year and 25% quarter-on-quarter. Demand remained strong across all end markets with automotive bookings recording a particularly steep increase in the fourth quarter. This was driven not only by the acceleration of car electrification but also by the pressure resulting from the ongoing chip shortage. Due to high order intake, which significantly exceeded short-term production capacities, X-FAB continued to allocate capacity to customers and backlog kept rising. As long as capacity will have to be allocated, it remains of utmost importance for X-FAB to ensure customers receive the minimum quantities necessary to avoid disruptions in their supply chains.

Supported by strong demand, efforts to move business to X-FAB France brought the site’s share of revenues based on X-FAB technologies up to 48%. The process of converting the French site’s capacity to manufacture X-FAB’s core technologies is ongoing with new equipment being delivered and installed regularly. This will contribute positively to meeting the high demand, in particular for X-FAB’s much sought after 180nm automotive technology.

Prototyping revenues in the fourth quarter were at USD 24.2 million, up 9% year-on-year and down 6% quarter-on-quarter after the previous quarter had been exceptionally strong. For the full year 2021, X-FAB recorded prototyping revenues of USD 89.2 million, up 32% compared to 2020.

Prototyping and production revenue per quarter and end market:

in millions

of USD

Revenue

Q4 2020

Q1 2021

Q2 2021

Q3 2021

Q4 2021

Q4 y-o-y growth

Automotive

Prototyping

3.6

3.2

3.0

3.5

3.6

2%

Production

61.8

80.4

79.8

78.0

80.2

30%

Industrial

Prototyping

8.2

9.0

10.3

12.9

11.5

40%

Production

19.0

23.3

24.9

25.4

28.2

48%

Medical

Prototyping

6.9

2.2

2.9

4.1

4.0

-43%

Production

5.1

6.4

7.5

10.2

10.6

107%

CCC

Prototyping

3.2

4.3

4.1

4.8

4.5

40%

Production

27.7

26.3

28.3

29.9

29.5

7%

Operations update

In the fourth quarter, all factories continued to run at high load. Productivity improvements remained the top priority to further increase wafer output while ensuring an excellent execution of all orders. The most important measures include eliminating production bottlenecks and recruiting additional staff.

X-FAB’s SiC activities further accelerated. For the full year, SiC revenues came in at USD 33.8 million which was a 61% increase over the previous year. In the fourth quarter, SiC revenues set a new record at USD 10.6 million, up 70% year-on-year and 7% quarter-on-quarter. Quarterly SiC bookings amounted to USD 17.0 million, up 141% year-on-year and 51% quarter-on-quarter. In line with strong demand, X-FAB kicked off investments to significantly expand its SiC manufacturing as well as in-house SiC epitaxy capacity to be available by the end of this year. According to customer feedback, X-FAB’s SiC line delivers quality and yield that is above industry average. While there is a lot of interest coming from new customers, the current main focus is on supporting existing accounts with products in development to progress with the launch of volume production.

In 2021, X-FAB invested across all sites to expand capacities in response to the strong demand and the expected growth going forward. Capital expenditures in the fourth quarter amounted to USD 21.1 million. For the full year, capital expenditures totaled USD 67.0 million, up 74% against the previous year. Apart from maintenance capex, these were mainly prepayments for new equipment ordered in 2021 as part of X-FAB’s capacity expansion program. Most of these new tools are expected to be delivered in the course of the current year and will have to be paid in full after delivery and installation. The reported capex does therefore not reflect the total volume of investment projects initiated in 2021, which amounted to approx. USD 190 million. As the new equipment becomes available, it will contribute positively to an increase of the wafer output. Main portion of the investments relates to the conversion of the French site’s capacity for the production of X-FAB technologies, the expansion of capacity at X-FAB Sarawak in Malaysia as well as the expansion of X-FAB’s SiC capacity at X-FAB Texas.

Financial update

Fourth quarter EBITDA was USD 33.9 million with an EBITDA margin of 19.7%, within the guided 19-23%. For the full year 2021, EBITDA amounted to USD 153.3 million with an EBITDA margin of 23.3%.

Performance in the fourth quarter was impacted by operational challenges caused by an increased absence rate due to COVID-19-related infections or quarantines. In addition to this, cost of sales went up due to price increases related to raw materials, spare parts, electricity and transportation. Although unfinished and finished goods inventory recorded an increase of USD 7.9 million, its contribution to profitability was limited. With a high number of SiC wafer starts, the main portion of this increase relates to the SiC substrate value.

Cash and cash equivalents at the end of the fourth quarter were USD 290.2 million, up 28% from the end of the previous quarter. Compared to the end of 2020, X-FAB’s cash position increased 41% driven by the positive cash flow from operating activities as well as from financing activities. With a total of USD 109.3 million, cash flow from operating activities recorded 47% increase over the previous year and fully covered 2021 capital expenditures.

The share of Euro-denominated sales in the fourth quarter amounted to 41%, which is in line with the level of costs incurred in Euro. This natural hedging of the business makes X-FAB’s profitability development largely independent of exchange rate fluctuations.

The actual US-Dollar/Euro exchange rate for the fourth quarter of 2021 was 1.14 leading to an EBITDA margin of 19.7%. At a constant exchange rate of 1.19, as experienced in the fourth quarter 2020, the EBITDA margin would have been 19.4%.

Management comments

Rudi De Winter, CEO of X-FAB Group, said: “I am very excited about the strong business development and how well X-FAB is positioned to benefit from the transition to green energy in automotive and industrial as well as the increasing deployment of reliable testing and point-of-care applications in medical. The ever-growing need for semiconductor-based innovative solutions will ensure healthy demand for our specialty technologies in the long term. In the short term, it is key to manage the challenges arising from the tremendous demand requiring full attention and commitment of all X-FAB teams. Our key focus has been and will be on execution excellence and productivity improvements for the best possible supply to our customers. The installation and qualification of new tools to remove bottlenecks will particularly contribute to an increase of wafer output going forward. While it is currently not clear how the semiconductor industry and, in light of all the uncertainties, the world economy will evolve, I am confident that X-FAB is perfectly placed to achieve its growth targets for 2022 and beyond.”

Procedures of the independent auditor

The statutory auditor, KPMG Bedrijfsrevisoren – Réviseurs d’Entreprises BV/SRL, represented by Jos Briers, has confirmed that the audit procedures, which have been substantially completed, have not revealed any material misstatement in the accounting information included in the Company’s annual announcement.

X-FAB Quarterly Conference Call

X-FAB’s fourth quarter results will be discussed in a live conference call on Thursday, February 10, 2022, at 6.30 p.m. CET. The conference call will be in English. Please register in advance of the conference using the following link: http://emea.directeventreg.com/registration/9650368.

Upon registering, you will be provided with participant dial-in numbers, Direct Event passcode and a unique registrant ID. In the 10 minutes prior to the call, you will need to use the conference access information provided in the email received at the point of registering.

The conference call will be available for replay from February 10, 2022, 11.30 p.m. CET until February 17, 2022, 11.30 p.m. CET. The replay number will be +44 (0) 3333009785, conference ID 9650368.

The first quarter 2022 results will be communicated on April 28, 2022.

About X-FAB

X-FAB is the leading analog/mixed-signal and MEMS foundry group manufacturing silicon wafers for automotive, industrial, consumer, medical and other applications. Its customers worldwide benefit from the highest quality standards, manufacturing excellence and innovative solutions by using X-FAB’s modular CMOS processes in geometries ranging from 1.0 to 0.13 µm, and its special silicon carbide and MEMS long-lifetime processes. X-FAB’s analog-digital integrated circuits (mixed-signal ICs), sensors and micro-electro-mechanical systems (MEMS) are manufactured at six production facilities in Germany, France, Malaysia and the U.S. X-FAB employs about 4,000 people worldwide. For more information, please visit www.xfab.com.

Forward-looking information

This press release may include forward-looking statements. Forward-looking statements are statements regarding or based upon our management’s current intentions, beliefs or expectations relating to, among other things, X-FAB’s future results of operations, financial condition, liquidity, prospects, growth, strategies or developments in the industry in which we operate. By their nature, forward-looking statements are subject to risks, uncertainties and assumptions that could cause actual results or future events to differ materially from those expressed or implied thereby. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein.

Forward-looking statements contained in this press release regarding trends or current activities should not be taken as a report that such trends or activities will continue in the future. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless legally required. You should not place undue reliance on any such forward-looking statements, which speak only as of the date of this press release.

The information contained in this press release is subject to change without notice. No re-report or warranty, express or implied, is made as to the fairness, accuracy, reasonableness, or completeness of the information contained herein and no reliance should be placed on it.

Condensed Consolidated Statement of Profit and Loss

in thousands of USD

Quarter

ended 31 Dec 2021

unaudited

Quarter

ended 31 Dec 2020

unaudited

Quarter

ended 30 Sep 2021

unaudited

Year

ended 31 Dec 2021

unaudited

Year

ended 31 Dec 2020

audited

Revenue

172,279

135,851

169,097

657,751

477,586

Revenues in USD in %

59

66

60

63

68

Revenues in EUR in %

41

34

40

37

32

Cost of sales

-138,351

-116,258

-129,773

-507,773

-433,852

Gross Profit

33,928

19,593

39,323

149,978

43,734

Gross Profit margin in %

19.7

14.4

23.3

22.8

9.2

 

 

 

 

 

 

Research and development expenses

-9,383

-9,559

-7,751

-34,308

-26,812

Selling expenses

-1,922

-2,077

-1,969

-8,017

-8,005

General and administrative expenses

-8,651

-8,065

-8,320

-32,771

-29,610

Rental income and expenses from investment properties

181

703

422

1,898

1,691

Other income and other expenses

38

3,026

-340

412

4,385

Operating profit

14,192

3,621

21,366

77,192

-14,617

Finance income

3,196

43,016

5,166

16,115

54,187

Finance costs

-4,143

-5,080

-6,027

-20,441

-22,015

Net financial result

-947

37,936

-861

-4,326

32,172

 

 

 

 

 

 

Profit before tax

13,245

41,557

20,505

72,866

17,555

Income tax

9,083

-2,486

1,296

10,774

-4,025

Profit for the period

22,327

39,072

21,801

83,640

13,530

 

 

 

 

 

 

Operating profit (EBIT)

14,192

3,621

21,366

77,192

-14,617

Depreciation

19,748

18,879

19,076

76,093

75,067

EBITDA

33,940

22,500

40,442

153,286

60,450

EBITDA margin in %

19,7

16,6

23,9

23,3

12,7

 

 

 

 

 

 

Earnings per share at the end of period

0,17

0,30

0,17

0,64

0,10

Weighted average number of shares

130,631,921

130,631,921

130,631,921

130,631,921

130,631,921

 

 

 

 

 

 

EUR/USD average exchange rate

1.14382

1.19146

1.17954

1.18331

1.14126

 

 

Amounts in the financial tables provided in this press release are rounded to the nearest thousand except when otherwise indicated, rounding differences may occur.

Condensed Consolidated Statement of Financial Position

in thousands of USD

Year ended

31 Dec 2021

unaudited

Year ended

31 Dec 2020

audited

ASSETS

 

 

Non-current assets

 

 

Property, plant, and equipment

340,670

336,848

Investment properties

8,310

8,556

Intangible assets

4,034

4,726

Other non-current assets

28

68

Deferred tax assets

26,000

30,392

Total non-current assets

379,042

380,590

 

 

 

Current assets

 

 

Inventories

181,014

153,711

Trade and other receivables

73,689

54,576

Other assets

43,354

38,054

Cash and cash equivalents

290,187

205,867

Deferred tax assets (short-term)

19,645

0

Total current assets

607,889

452,208

 

 

 

TOTAL ASSETS

986,931

832,798

 

 

 

EQUITY AND LIABILITIES

 

 

Equity

 

 

Share capital

432,745

432,745

Share premium

348,709

348,709

Retained earnings

-36,154

-120,603

Cumulative translation adjustment

-559

-747

Treasury shares

-770

-770

Total equity attributable to equity holders of the parent

743,971

659,334

 

 

 

Non-controlling interests

365

344

 

 

 

Total equity

744,335

659,677

 

 

 

Non-current liabilities

 

 

Non-current loans and borrowings

39,917

44,413

Other non-current liabilities and provisions

5,686

4,371

Total non-current liabilities

45,602

48,784

 

 

 

Current liabilities

 

 

Trade payables

41,364

27,882

Current loans and borrowings

87,114

31,796

Other current liabilities and provisions

68,515

64,658

Total current liabilities

196,993

124,336

 

 

 

TOTAL EQUITY AND LIABILITIES

986,931

832,798

Condensed Consolidated Statement of Cash Flow

in thousands of USD

Quarter

ended 31 Dec 2021

unaudited

Quarter

ended 31 Dec 2020

unaudited

Quarter

ended 30 Sep 2021

unaudited

Year

ended 31 Dec 2021

unaudited

Year

ended 31 Dec 2020

audited

Income before taxes

13,245

41,557

20,505

72,866

17,555

 

 

 

 

 

 

Reconciliation of net income to cash flow arising from operating activities:

18,518

-20,219

18,131

70,319

34,404

Depreciation and amortization, before effect of grants and subsidies

19,748

18,879

19,076

76,093

75,067

Recognized investment grants and subsidies netted with depreciation and amortization

-991

-850

-850

-3,530

-3,453

Interest income and expenses (net)

203

-1,601

-139

-176

379

Loss/(gain) on the sale of plant, property, and equipment (net)

37

-2,668

80

-275

-3,253

Loss/(gain) on the change in fair value of derivatives (net) and financial assets (net)

0

0

0

0

-420

Other non-cash transactions (net)

-480

-33,978

-36

-1,793

-33,915

 

 

 

 

 

 

Changes in working capital:

-14,312

10,852

15,565

-31,806

23,032

Decrease/(increase) of trade receivables

1,027

-3,592

1,439

-9,769

362

Decrease/(increase) of other receivables & prepaid expenses

-3,456

5,433

10,743

-4,267

25,510

Decrease/(increase) of inventories

-8,454

6,377

-10,324

-27,302

936

(Decrease)/increase of trade payables

301

4,611

4,446

5,146

-10,970

(Decrease)/increase of other liabilities

-3,731

-1,978

9,261

4,386

7,194

 

 

 

 

 

 

Income taxes (paid)/received

-134

187

-220

-2,101

-645

 

 

 

 

 

 

Cash Flow from operating activities

17,316

32,377

53,981

109,278

74,346

 

 

 

 

 

 

Cash Flow from investing activities:

 

 

 

 

 

Payments for property, plant, equipment & intangible assets

-21,122

-14,611

-21,932

-66,972

-38,460

Proceeds from sale of financial assets

0

0

0

0

1,156

Payments for loan investments to related parties

-626

-39

-72

-827

-211

Proceeds from loan investments related parties

45

40

42

211

193

Proceeds from sale of property, plant, and equipment

220

2,002

47

669

3,528

Interest received

380

459

451

1,769

1,864

 

 

 

 

 

 

Cash Flow used in investing activities

-21,104

-12,149

-21,464

-65,149

-31,929

Condensed Consolidated Statement of Cash Flow – con’t

in thousands of USD

Quarter

ended 31 Dec 2021

unaudited

Quarter

ended 31 Dec 2020

unaudited

Quarter

ended 30 Sep 2021

unaudited

Year

ended 31 Dec 2021

unaudited

Year

ended 31 Dec 2020

audited

Cash Flow from (used in) financing activities:

 

 

 

 

 

Proceeds from loans and borrowings

77,796

8,660

310

82,585

17,208

Repayment of loans and borrowings

-7,807

-6,232

-8,561

-28,218

-26,950

Payments of lease installments

-1,057

-1,130

-1,335

-5,094

-5,331

Receipt of government grants and subsidies

535

0

0

535

696

Interest paid

-325

-1,617

-312

-1,335

-2,244

Distribution to non-controlling interests

0

0

0

-12

-12

 

 

 

 

 

 

Cash Flow from (used in) financing activities

69,142

-318

-9,898

48,461

-16,633

 

 

 

 

 

 

Effect of changes in foreign currency exchange rates on cash

-1,180

6,295

-1,715

-8,269

6,872

Increase/(decrease) of cash and cash equivalents

65,354

19,909

22,619

92,589

25,783

Cash and cash equivalents at the beginning of the period

226,013

179,662

205,109

205,867

173,211

Cash and cash equivalents at the end of

the period

290,187

205,867

226,013

290,187

205,867

###

X-FAB Press Contact Uta Steinbrecher Investor Relations X-FAB Silicon Foundries +49-361-427-6489 uta.steinbrecher@xfab.com

X-FAB Silicon Foundries (EU:XFAB)
Historical Stock Chart
Von Nov 2022 bis Dez 2022 Click Here for more X-FAB Silicon Foundries Charts.
X-FAB Silicon Foundries (EU:XFAB)
Historical Stock Chart
Von Dez 2021 bis Dez 2022 Click Here for more X-FAB Silicon Foundries Charts.